[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT05534516":3,"trial-entities:NCT05534516":80,"trial-summary:NCT05534516":84},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":21,"primary_purpose":17,"phases":22,"enrollment_info":23,"interventions":26,"primary_outcomes":27,"secondary_outcomes":44,"sex":45,"minimum_age":46,"maximum_age":47,"healthy_volunteers":15,"eligibility_criteria":48,"std_ages":57,"locations":60,"central_contacts":70,"overall_officials":71,"references":75,"see_also_links":76},"NCT05534516","22-006064","A Study of Physiologic Changes in a Telemetry Unit","Physiologic Changes Associated With Health Deterioration, Medications and Fluids Used in the Telemetry Unit","ENROLLING_BY_INVITATION","2027-08","2025-09","2025-10-01","2023-02-22","Mayo Clinic","OTHER",false,"The purpose of this study is to determine the physiological changes associated with health deterioration, as well as different types, doses, and routes of administration of medications and fluids in acutely ill patients.",null,[19],"Acute Illness Requiring to Hospital Telemetry Admission",[],"OBSERVATIONAL",[],{"count":24,"type":25},500,"ESTIMATED",[],[28,32,35,38,41],{"measure":29,"description":30,"timeFrame":31},"Change in Heart Rate","Number of beats per minute","Baseline, through telemetry unit stay (approximately 1-3 days)",{"measure":33,"description":34,"timeFrame":31},"Change in Blood Pressure","Measured in millimeters of mercury (mmHg)",{"measure":36,"description":37,"timeFrame":31},"Change in Respiratory Rate","Number of breaths per minute",{"measure":39,"description":40,"timeFrame":31},"Change in Oxygen Saturation Levels","Measured by a pulse oximeter reading reported as a percentage",{"measure":42,"description":43,"timeFrame":31},"Change in ECG morphology","Changes in ECG waveform appearance measured from the digital ECG waveform interpretation",[],"ALL","18 Years","65 Years",{"inclusion":49,"exclusion":55,"raw_text":56},[50,51,52,53,54],"Admitted to telemetry unit","With acute illness","Received any type of medication via any route of administration (oral, sublingual, intranasal, inhalational, intramuscular, intravenous, subcutaneous, transdermal)","Received any amount of any type of intravenous fluids","Cognitively and\u002For physically be able to sign consent",[],"Inclusion Criteria: Mayo Clinic patients who:\n\n* Admitted to telemetry unit\n* With acute illness\n* Received any type of medication via any route of administration (oral, sublingual, intranasal, inhalational, intramuscular, intravenous, subcutaneous, transdermal)\n* Received any amount of any type of intravenous fluids\n* Cognitively and\u002For physically be able to sign consent\n\nExclusion Criteria:\n\n\\- None",[58,59],"ADULT","OLDER_ADULT",[61],{"facility":62,"city":63,"state":64,"zip":65,"country":66,"geoPoint":67},"Mayo Clinic Florida","Jacksonville","Florida","32224","United States",{"lat":68,"lon":69},30.33218,-81.65565,[],[72],{"name":73,"affiliation":13,"role":74},"Antonio Forte, MD, PhD","PRINCIPAL_INVESTIGATOR",[],[77],{"label":78,"url":79},"Mayo Clinic Clinical Trials","https:\u002F\u002Fwww.mayo.edu\u002Fresearch\u002Fclinical-trials",{"nct_id":4,"conditions":81,"biomarkers":83},[82],"Acute illness",[],{"nct_id":4,"found":15,"summary":17,"prompt_version":17}]